BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 8393184)

  • 1. [Treatment with extractive growth hormone and Creutzfeld-Jakob encephalopathy: a new iatrogenic tragedy].
    Battin J
    Pediatrie; 1993; 48(2):91-5. PubMed ID: 8393184
    [No Abstract]   [Full Text] [Related]  

  • 2. [Iatrogenic Creutzfeld-Jakob disease induced by the administration of extracted growth hormone].
    Rev Neurol (Paris); 1993; 149(10):515-6. PubMed ID: 8023062
    [No Abstract]   [Full Text] [Related]  

  • 3. [Creutzfeldt-Jakob disease in 4 children treated with growth hormone].
    Billette de Villemeur T; Gourmelen M; Beauvais P; Rodriguez D; Vaudour G; Deslys JP; Dormont D; Richard P; Richardet JM
    Rev Neurol (Paris); 1992; 148(5):328-34. PubMed ID: 1448646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission of Creutzfeldt-Jakob disease by investigative and therapeutic procedures.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1991; 10(2):89-98. PubMed ID: 1932464
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hypophyseal growth hormone and Creutzfeldt-Jakob disease in The Netherlands. Ad hoc Commission Creutzfeldt-Jakob-disease of the Dutch Growth Foundation].
    Rikken B; Massa GG; Wit JM; van den Brande JL
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1163-5. PubMed ID: 8692348
    [No Abstract]   [Full Text] [Related]  

  • 6. [Uses of growth hormone].
    Rodríguez Hierro F
    Med Clin (Barc); 1986 Sep; 87(7):288-90. PubMed ID: 3531738
    [No Abstract]   [Full Text] [Related]  

  • 7. [Iatrogenic Creutzfeld-Jakob disease. Significance of cases observed after extracted growth hormone treatment].
    Billette de Villemeur T
    Rev Neurol (Paris); 1998 Oct; 154(10):651-2. PubMed ID: 9846334
    [No Abstract]   [Full Text] [Related]  

  • 8. [Creutzfeldt-Jakob disease after treatment with human extracted growth hormone. A clinicopathological study].
    Delisle MB; Fabre N; Rochiccioli P; Doerr-Schott J; Rumeau JL; Bes A
    Rev Neurol (Paris); 1993; 149(10):524-7. PubMed ID: 8023064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creutzfeldt-Jakob disease after pituitary-derived human growth hormone therapy: two cases with valine 129 homozygous genotype.
    Masson C; Delalande I; Deslys JP; Hénin D; Fallet-Bianco C; Dormont D; Leys D
    Neurology; 1994 Jan; 44(1):179-80. PubMed ID: 7904734
    [No Abstract]   [Full Text] [Related]  

  • 10. The human growth hormone Creutzfeld Jakob disease litigation.
    Owen R
    Med Leg J; 1997; 65 ( Pt 2)():46-64. PubMed ID: 9241994
    [No Abstract]   [Full Text] [Related]  

  • 11. [Creutzfeldt-Jakob disease].
    Acta Med Port; 1986; 7(1):69. PubMed ID: 3524123
    [No Abstract]   [Full Text] [Related]  

  • 12. Iatrogenic Creutzfeldt-Jakob disease in three growth hormone recipients: a neuropathological study.
    Billette de Villemeur T; Gelot A; Deslys JP; Dormont D; Duyckaerts C; Jardin L; Denni J; Robain O
    Neuropathol Appl Neurobiol; 1994 Apr; 20(2):111-7. PubMed ID: 8072642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts.
    Brown P
    Pediatrics; 1988 Jan; 81(1):85-92. PubMed ID: 3275936
    [No Abstract]   [Full Text] [Related]  

  • 14. [A patient with Creutzfeldt-Jakob disease following treatment with human growth hormone].
    Roos RA; Wintzen AR; Will RG; Ironside JW; van Duinen SG
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1190-3. PubMed ID: 8692356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pituitary growth hormone and Creutzfeldt-Jakob disease.
    Preece M
    Horm Res; 1993; 39(3-4):95-8. PubMed ID: 8262483
    [No Abstract]   [Full Text] [Related]  

  • 16. Human growth hormone-related iatrogenic Creutzfeldt-Jakob disease: search for a genetic susceptibility by analysis of the PRNP coding region.
    Jaegly A; Boussin F; Deslys JP; Dormont D
    Genomics; 1995 May; 27(2):382-3. PubMed ID: 7558015
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of children with short stature with human growth hormone and its potential risks].
    Sizonenko PC
    Arch Fr Pediatr; 1993 May; 50(5):369-74. PubMed ID: 8239885
    [No Abstract]   [Full Text] [Related]  

  • 18. Creutzfeldt-Jakob disease after administration of human growth hormone.
    Powell-Jackson J; Weller RO; Kennedy P; Preece MA; Whitcombe EM; Newsom-Davis J
    Lancet; 1985 Aug; 2(8449):244-6. PubMed ID: 2862420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal degenerative neurologic disease in patients who received pituitary-derived human growth hormone.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(24):359-60, 365-6. PubMed ID: 3923319
    [No Abstract]   [Full Text] [Related]  

  • 20. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era.
    Brown P; Brandel JP; Preece M; Sato T
    Neurology; 2006 Aug; 67(3):389-93. PubMed ID: 16855204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.